Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.
- DOI
- 10.1016/s0140-6736(26)01861-1
- Published
- 2026 Oct 10
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-01861-1,
title = {Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.},
author = {Bellido V and le Roux CW and Ekinci EI and Bjornstad P and Frias JP and Giblin K and Eyde S and Park SY and Ferro J and Johnson C and Taylor A},
year = {2026},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(26)01861-1},
url = {https://doi.org/10.1016/s0140-6736(26)01861-1}
}RIS
TY - JOUR TI - Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial. AU - Bellido V AU - le Roux CW AU - Ekinci EI AU - Bjornstad P AU - Frias JP AU - Giblin K AU - Eyde S AU - Park SY AU - Ferro J AU - Johnson C AU - Taylor A PY - 2026 JO - Lancet (London, England) DO - 10.1016/s0140-6736(26)01861-1 UR - https://doi.org/10.1016/s0140-6736(26)01861-1 ER -
APA
V, B., CW, L. R., EI, E., P, B., JP, F., K, G., S, E., SY, P., J, F., C, J., & A, T. (2026). Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01861-1
Source records
- pubmed · retrieved 2026-11-10T14:13:59.372Z